Last $56.16 USD
Change Today +1.02 / 1.85%
Volume 231.0K
ALKS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard F. Pops

Chairman of the Board and Chief Executive Officer, Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 150 board members in 9 different organizations across 5 different industries.

See Board Relationships
52$6,587,779
As of Fiscal Year 2013

Background*

Mr. Richard F. Pops has been the Chief Executive Officer of Alkermes PLC since September 11, 2009. Mr. Pops founded Genomics Collaborative, Inc and served as its Director. He Co-Founded Sirtris Pharmaceuticals, Inc. and served as its Director from 2004 to 2008. He served as the President of Alkermes PLC from September 11, 2009 to September 16, 2011 and previously served as its Chief Executive Officer from February 1991 to April 1, 2007. Prior to Alkermes, he was employed ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 772 8000
Fax: --

Board Members Memberships*

Founder and Director
Director At Large
Director
Trustee
Director
Director
Former Director
1991-Present
Chairman of the Board and Chief Executive Officer
1998-Present
Independent Director, Chairman of Compensation Committee and Member of Audit Committee
2001-2009
Former Independent Director and Chairman of Compensation Committee
2004-Present
Director
2004-N/A
Co-Founder
2006-N/A
Former Director
2008-Present
Independent Director and Member of Audit Committee

Education*

BA 1983
The Leland Stanford Junior University

Other Affiliations*

Annual Compensation*

Salary$810,154
Total Annual Compensation$810,154

Stock Options*

Restricted Stock Awards$537,875
All Other Compensation$12,750
Exercised Options333,750
Exercised Options Value$5,997,265
Exercisable Options2,497,500
Exercisable Options Value$68,104,888
Unexercisable Options918,750
Unexercisable Options Value$17,079,875
Total Value of Options$91,182,027
Total Number of Options3,750,000

Total Compensation*

Total Annual Cash Compensation$2,422,904
Total Short Term Compensation$810,154
Other Long Term Compensation$550,625
Total Calculated Compensation$6,587,779
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALKS:US $56.16 USD +1.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
$916.2K
Carolyn J. Logan Chief Executive Officer, President and Director
Salix Pharmaceuticals Ltd.
$867.5K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Vinita Gupta Chief Executive Officer, Executive Director, Chief Executive Officer of Lupin Pharmacuticls Inc Usa and Group President of Lupin Pharmacuticls Inc Usa
Lupin Limited
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.